Safety and efficacy of current direct-acting antiviral regimens in kidney and liver transplant recipients with hepatitis C: Results from the HCV-TARGET study.
about
Effectiveness of current and future regimens for treating genotype 3 hepatitis C virus infection: a large-scale systematic review.Curing hepatitis C virus (HCV) after organ transplantation: Increased risk of rejection following HCV elimination.Prevalence and impact of baseline resistance-associated substitutions on the efficacy of ledipasvir/sofosbuvir or simeprevir/sofosbuvir against GT1 HCV infection.What do clinicians need to watch for with direct-acting antiviral therapy?Successful combination of direct antiviral agents in liver-transplanted patients with recurrent hepatitis C virus.Impact of new DAA therapy on real clinical practice: a multicenter region-wide cohort study.Hepatitis C Virus Treatment in Patients With Chronic Kidney Disease and in Kidney Transplant Recipients.Use of direct antiviral agents in liver transplant recipients with hepatitis C virus in Korea: 2-center experienceHepatitis C and renal transplantation in era of new antiviral agents
P2860
Q45324737-AE0CD3AC-D4A7-4B45-AFBC-27E90A14359EQ45325786-D7F52E1D-FB71-4725-BEA8-26C3C2424209Q49911983-FBEEE8F0-2D29-4D5B-A04D-EB3B0CDEA2D0Q52327014-3E9471C2-D175-4CD7-A4B0-8FA8DD664683Q54245484-F7FDC204-A3E2-479A-A41D-E2485C734259Q55056866-5EBFDBB6-D66E-44DC-88B3-1A676B6D1850Q55508515-D8C3AD01-9D04-4B39-9B1B-ED20D7D1C36AQ57213140-7D998C90-C4CA-4DE9-BA06-9282B2801973Q58792851-CE4C1D5D-C37E-404D-91E6-0927B2DFDEDE
P2860
Safety and efficacy of current direct-acting antiviral regimens in kidney and liver transplant recipients with hepatitis C: Results from the HCV-TARGET study.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Safety and efficacy of current ...... lts from the HCV-TARGET study.
@en
type
label
Safety and efficacy of current ...... lts from the HCV-TARGET study.
@en
prefLabel
Safety and efficacy of current ...... lts from the HCV-TARGET study.
@en
P2093
P2860
P356
P1433
P1476
Safety and efficacy of current ...... lts from the HCV-TARGET study.
@en
P2093
Alexander A Kuo
David R Nelson
Elizabeth C Verna
Farrukh Koraishy
Jacqueline G O'Leary
Joseph S Galati
Josh Levitsky
Lucy Akushevich
Mark S Sulkowski
Michael W Fried
P2860
P356
10.1002/HEP.29258
P407
P577
2017-05-15T00:00:00Z